Stockholm, Sweden Saturday, February 22, 2025, 09:00 Hrs [IST] ...

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte ...

Gilead Sciences (GILD) said on Friday that the European Commission (EC) granted conditional marketing authorization for ...

On the downside, the US Dollar Index may test the lower boundary of the descending channel at 106.10, followed by the key psychological level of 106.00. A break below this critical support zone could ...

While Health Technology Assessment agencies anticipate that joint efforts and harmonisation will enhance evaluations’ efficiency, tangible evidence is taking time to materialise.

Inflation, wage growth, and BoJ rate hike bets fuel gains. Can US PMI data shift USD/JPY direction? Key levels in focus.

Gilead Sciences, Inc. today announced that the European Commission (EC) has granted conditional marketing authorization for seladelpar for the treatment of primary biliary cholangitis (PBC) in ...

We recently published a list of 12 Best Global Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ:AZN) stands against other best ...

Celltrion expands its reach in Europe, securing marketing authorization from the European Commission (EC) for its denosumab biosimilar candidate (Stoboclo and Osenvelt) and its aflibercept biosimilar ...

Biliary tract cancer is increasing in incidence and mortality across Europe, with more people under the age of 60 years old ...